21181-Prostate Cancer-NA-1591

Prostate Cancer

Randomized Phase 2b Study of ZEN003694 in Combination with Enzalutamide versus Enzalutamide Monotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (ZEN003694-201)

  • Details

ClinicalTrials.gov ID: NCT04986423
Diagnosis Type: NA
USOR Number:

  • Address


,
P:

Search by practice name, trial titles, indicators and specific disease types.